Since Crisfield's founding on the Chesapeake Bay, the environment has been an important part of community life, economy and culture. In an effort to deal with current environmental challenges such as nuisance flooding, storms, and erosion, the U.S. Environmental Protection Agency is partnering with the City of Crisfield and Maryland Sea Grant to explore nature-based solutions to flooding such as green infrastructure and marsh restoration. Join a team of Crisfield area residents in the Crisfield Resilience Academy to work with scientists and co-develop community solutions to issues associated with local flooding. For additional information, please join the upcoming informational webinar or contact Jenna Hartley at hartley.jenna@epa.gov. Crisfield Resilience Academy participants will receive a stipend of up to $400/six months for participating.

If you have high risk prostate cancer, you may be able to participate in a research study to find out decreasing or increasing your radiation and hormonal therapy has an effect on your cancer.

In this study, we want to learn if a combination of two drugs (fianlimab and cemiplimab) is an effective treatment compared to a drug called pembrolizumab for people who have had melanoma removal surgery but are still at high risk for recurrence of the disease.

This is a Phase 1b/2, multicenter, open-label, basket study evaluating ACR-368, an adenosine triphosphate-competitive selective inhibitor of checkpoint kinase (CHK)1 and CHK2, as monotherapy and in combination with ultralow-dose gemcitabine (ULDG), in the treatment of subjects with histologically confirmed, locally advanced or metastatic, recurrent platinum-resistant high-grade ovarian or endometrial adenocarcinoma, or platinum-resistant urothelial carcinoma (hereafter referred to as ovarian, endometrial, and urothelial, respectively).

Do you wonder about your mobility as you age? You may be eligible to participate in a research study investigating age effects on foot-ankle interactions with carbon fiber insoles. The goal of this study is to enhance foot and ankle function in aging and mobility. Compensation provided.

If you have Testosterone-driven Salivary Gland Cancer, you may be able to participate in a research study testing the anti-cancer drug Darolutamide.

The purpose of this study is to test good and bad effects of different drugs against metastatic brain tumors with altered genes. This trial is trying to see if tumor genetic testing would be helpful at guiding treatment in patients such as you. Researchers have looked at the DNA material (genes) that can be affected in brain metastases and have found several genes that are altered, or mutated. There are medications that target these genes. We are doing this study because we want to find out if this approach is better or worse than the usual approach for your metastatic cancer. The usual approach is defined as care most people get for your metastatic cancer.

Have you been diagnosed with Prostate, Bladder, or Kidney Cancer? If so, you may be able to take part in a research study investigating the optimal way to combine or sequence therapies in patients with Rare Genitourinary Tumors.

Have you been diagnosed with extremity soft tissue sarcoma and are scheduled to have standard of care radiotherapy (XRT) followed by surgery to treat your cancer? XRT is effective in managing extremity soft tissue sarcoma, however, it is associated with risks, such as damage to healthy tissue, and complications in post-surgery wound healing.

We are trying to understand responses to food labels among adults who identify as Hispanic/Latino.